基本信息
views: 169
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Michael Staehler is the Head of the Interdisciplinary Centre for Renal Tumors at the Ludwig-Maximilians University of Munich, Germany.
He is Member of the Renal Cancer Workgroup of the German Cancer Society. He also serves as a member of the German Guideline Committee on Renal Cancer.
Following medical qualification at University of Munich Medical School and gaining experience in general, vascular and thoracic surgery at the University of Regensburg, the University of California in San Francisco and his training in Urology at the Free University, Berlin, he was awarded a PhD for his work on renal cancer at the University of Munich.
After joining the Department of Urology, he was appointed Consultant Urologist at Grosshadern Clinics and founded the Interdisciplinary Centre on Renal Tumors in Germany. He is also Head of the Urological Oncology Service for Advanced Genitourinary Cancer and Kidney surgery.
Professor Staehler’s main research interest has been the development of novel therapeutics in renal cell carcinoma, particularly in the area of radiation therapy, surgical therapy and novel targeted agents. He is a Medical Advisor to the German Kidney Cancer Association.
On the editorial board of several journals, Professor Staehler has published more than 70 articles on renal cancer and co-authored six textbooks.
He is Member of the Renal Cancer Workgroup of the German Cancer Society. He also serves as a member of the German Guideline Committee on Renal Cancer.
Following medical qualification at University of Munich Medical School and gaining experience in general, vascular and thoracic surgery at the University of Regensburg, the University of California in San Francisco and his training in Urology at the Free University, Berlin, he was awarded a PhD for his work on renal cancer at the University of Munich.
After joining the Department of Urology, he was appointed Consultant Urologist at Grosshadern Clinics and founded the Interdisciplinary Centre on Renal Tumors in Germany. He is also Head of the Urological Oncology Service for Advanced Genitourinary Cancer and Kidney surgery.
Professor Staehler’s main research interest has been the development of novel therapeutics in renal cell carcinoma, particularly in the area of radiation therapy, surgical therapy and novel targeted agents. He is a Medical Advisor to the German Kidney Cancer Association.
On the editorial board of several journals, Professor Staehler has published more than 70 articles on renal cancer and co-authored six textbooks.
He is Member of the Renal Cancer Workgroup of the German Cancer Society. He also serves as a member of the German Guideline Committee on Renal Cancer.
Following medical qualification at University of Munich Medical School and gaining experience in general, vascular and thoracic surgery at the University of Regensburg, the University of California in San Francisco and his training in Urology at the Free University, Berlin, he was awarded a PhD for his work on renal cancer at the University of Munich.
After joining the Department of Urology, he was appointed Consultant Urologist at Grosshadern Clinics and founded the Interdisciplinary Centre on Renal Tumors in Germany. He is also Head of the Urological Oncology Service for Advanced Genitourinary Cancer and Kidney surgery.
Professor Staehler’s main research interest has been the development of novel therapeutics in renal cell carcinoma, particularly in the area of radiation therapy, surgical therapy and novel targeted agents. He is a Medical Advisor to the German Kidney Cancer Association.
On the editorial board of several journals, Professor Staehler has published more than 70 articles on renal cancer and co-authored six textbooks.
He is Member of the Renal Cancer Workgroup of the German Cancer Society. He also serves as a member of the German Guideline Committee on Renal Cancer.
Following medical qualification at University of Munich Medical School and gaining experience in general, vascular and thoracic surgery at the University of Regensburg, the University of California in San Francisco and his training in Urology at the Free University, Berlin, he was awarded a PhD for his work on renal cancer at the University of Munich.
After joining the Department of Urology, he was appointed Consultant Urologist at Grosshadern Clinics and founded the Interdisciplinary Centre on Renal Tumors in Germany. He is also Head of the Urological Oncology Service for Advanced Genitourinary Cancer and Kidney surgery.
Professor Staehler’s main research interest has been the development of novel therapeutics in renal cell carcinoma, particularly in the area of radiation therapy, surgical therapy and novel targeted agents. He is a Medical Advisor to the German Kidney Cancer Association.
On the editorial board of several journals, Professor Staehler has published more than 70 articles on renal cancer and co-authored six textbooks.
Research Interests
Papers共 470 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Steven Leonard,Emma Helstrom, Andres Correa,Mohit Sindhani, Nicole Uzzo,Angela Y Jia,Alexander Kutikov,Robert Uzzo, Sarah P Psutka, Adam Calaway,Zachary Klaassen,Michael Staehler,
JCO oncology practicepp.OP2300733-OP2300733, (2024)
Goebell P.J., Radkowski R., Müller L., Ghasemi U.,Grünwald V., Deger S.,Andres-Pons A., Lennartz C.,Jänicke M.,Grüllich C.,Staehler M., Gratzke C.,
European Urology (2024): S1731
Nutrientsno. 11 (2024): 1630
CLINICAL GENITOURINARY CANCERno. 2 (2024): 189-192
CANCERSno. 1 (2024): 97
Theresa Hofmann, Nadja Kohlhase, Dochka Eftimova, Michael Martin Eder,Michael Staehler,Maximilian I. Ruge,Alexander Muacevic,Christoph Fürweger
Physica Medica (2024): 103372-103372
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn